Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
Open Access
- 31 May 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 13 (5), 476-486
- https://doi.org/10.1016/s1470-2045(12)70075-x
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- U.S. Department of Health and Human Services (24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221, N01WH22110)
- National Heart, Lung, and Blood Institute
This publication has 59 references indexed in Scilit:
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior HysterectomyJama-Journal Of The American Medical Association, 2011
- Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancerBreast Cancer Research and Treatment, 2010
- Hormone therapy and fatal breast cancerPharmacoepidemiology and Drug Safety, 2010
- Mammographic Screening and Risk Factors for Breast CancerAmerican Journal of Epidemiology, 2009
- Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast CancerJama-Journal Of The American Medical Association, 2009
- Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After MenopauseAmerican Journal of Epidemiology, 2009
- Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal WomenAmerican Journal of Epidemiology, 2008
- Estrogen Carcinogenesis in Breast CancerThe New England Journal of Medicine, 2006
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJama-Journal Of The American Medical Association, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003